Browser does not support script.
Skip to main content
search here
Macmillan and Cancerbackup merged in 2008. Together we provide free, high quality information for people affected by cancer through our publications, website and phone service. Find out more|.
Find out how we produce our information|
Cancer research trials are carried out to try to find new and better treatments for cancer. Trials that are carried out on patients are known as clinical trials|.
These may be carried out to:
Trials are the only reliable way to find out if a different operation, type of chemotherapy, radiotherapy|, or other treatment is better than what is already available.
You may be asked to take part in a treatment research trial. There can be many benefits in doing this. Trials help to improve knowledge about cancer and develop new treatments. You'll also be carefully monitored during and after the study. Usually, several hospitals around the country take part in these trials. It is important to bear in mind that some treatments that look promising at first are often later found not to be as good as existing treatments, or to have side effects that outweigh the benefits.
If you decide not to take part in a trial your decision will be respected and you don’t have to give a reason. If you do decide to take part, you’re allowed to withdraw from the trial at any time. In either case, there will be no change in the way that you are treated by the hospital staff and you’ll be offered the standard treatment for your situation.
Blood and tumour samples may be taken to help make the right diagnosis. You may be asked for your permission to use some of your samples for research into cancer.
If you are taking part in a trial you may also be asked to give other samples which may be frozen and stored for future use when new research techniques become available. These samples will have your name removed from them so you can’t be identified.
The research may be carried out at the hospital where you are treated, or it may take place at another one. This type of research takes a long time, and it may be many years before the results are known. The samples will, however, be used to increase knowledge about the causes of cancer and its treatment. This research will, hopefully, improve the outlook for future patients.
If you have papillary or follicular thyroid cancer you may be asked to take part in a trial called HiLo. The trial is trying to find out if low-dose radioactive iodine is as effective as the standard high-dose. The trial is also looking at how the drug recombinant human thyroid stimulating hormone| affects the way the radioactive iodine works. Some people taking part in the trial will be given rhTSH and others won’t. Your doctor can give you more information about this trial.
Another trial, for people with advanced thyroid cancer, is investigating a newer way of giving radiotherapy called intensity-modulated radiotherapy, or IMRT. This is a way of giving radiotherapy so that the treatment beams are shaped to the cancer and it allows the dose of radiotherapy to be altered over the whole treatment area, avoiding treating healthy tissue. Higher doses of radiotherapy can be given but with potentially fewer side effects. The trial is trying to find the best and safest dose of IMRT.
For answers, support or just a chat, call the Macmillan Support Line free (Monday to Friday, 9am-8pm)
If you have any questions about cancer, need support or just want someone to talk to, ask Macmillan.